Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Assets: 2009-2024

Historic Assets for Northwest Biotherapeutics (NWBO) over the last 16 years, with Dec 2024 value amounting to $26.7 million.

  • Northwest Biotherapeutics' Assets rose 4.39% to $30.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.6 million, marking a year-over-year increase of 4.39%. This contributed to the annual value of $26.7 million for FY2024, which is 4.08% down from last year.
  • Per Northwest Biotherapeutics' latest filing, its Assets stood at $26.7 million for FY2024, which was down 4.08% from $27.9 million recorded in FY2023.
  • In the past 5 years, Northwest Biotherapeutics' Assets registered a high of $40.2 million during FY2021, and its lowest value of $26.7 million during FY2024.
  • Moreover, its 3-year median value for Assets was $27.9 million (2023), whereas its average is $28.6 million.
  • In the last 5 years, Northwest Biotherapeutics' Assets soared by 209.11% in 2020 and then declined by 22.00% in 2022.
  • Over the past 5 years, Northwest Biotherapeutics' Assets (Yearly) stood at $32.9 million in 2020, then climbed by 22.07% to $40.2 million in 2021, then dropped by 22.00% to $31.3 million in 2022, then dropped by 11.04% to $27.9 million in 2023, then decreased by 4.08% to $26.7 million in 2024.